TOP 5 MOST VIEWED ARTICLES
RECENT COMMENTS
Article type: Best Cancer Reporter Award
Keywords: Linda Geddes, experimental drugs, DCA, Best Cancer Reporter Award, .
This article has 0 comments
Do-it-yourself Chemotherapy Access
Internet chatrooms offer patients a forum to discuss new therapies and exchange tips on how to get access to experimental drugs – sometimes from sources that have neither responsibility for nor interest in their welfare. Linda Geddes received an ESO Best Cancer Reporter Award for looking at the case of DCA, in her article When All Else Fails, which is republished below.
» Linda Geddes
To read the complete article please click on the pdf icon
COMMENTS (0)
When submitted, your comment will be moderated. Messages which may be considered defamatory, which incite hatred or contain foul or abusive language, or are gratuitously offensive, will not be published. Please ensure that your comments are concise and relevant to the topic in question. Off-topic comments and comments without a username will not be published.
ESO reserves the absolute right not to publish comments.
ESO reserves the absolute right not to publish comments.
CancerWorld invites you to visit:
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, AstraZeneca, Eisai, Eli Lilly, GlaxoSmithKline, Merck and Novartis.






